Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COESPINE: Dexamethasone in ESP Block for Cardiac Surgery
NCT04313959Phase 3Unknown
- Sponsor
- Instituto do Coração
- Start
- Jan 2022
- Primary completion
- Feb 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in postoperative pain (2 arms), sponsored by Instituto do Coração. Primary endpoint: Pain intensity score at 7 days. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04313959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04313959.